Thompson Peter A. Insider Trades

Insider Trading History

Track insider trading activity for Thompson Peter A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $0 0 shares
Last Trade
Jan 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.75M 210,000 shares
$22.61
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $2.44M 210,000 shares
Last Trade
Jan 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.75M 210,000 shares
$22.61
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $0 0 shares
Last Trade
Jun 27, 2025 Sale (In The Money)Reported as In The Money on SEC Form 4.
$5.44M 1,397,684 shares
$3.89
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $96.8M 8,341,338 shares
Last Trade
Jun 27, 2025 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$5.44M 1,397,684 shares
$3.89
$11.60
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $83.1M 7,165,006 shares
Last Trade
Jun 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.89M 1,176,332 shares
$4.16
$11.60
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $263k 30,000 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$518k 30,000 shares
$17.26
$8.75
Edgewise Therapeutics
Edgewise Therapeutics EWTX
10% owner
Holding Value $1.09M 30,000 shares
Last Trade
Jun 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$440k 30,000 shares
$14.68
$36.21
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $174k 15,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.6k 15,000 shares
$4.24
$11.60
Edgewise Therapeutics
Edgewise Therapeutics EWTX
10% owner
Holding Value $536M 14,809,075 shares
Last Trade
Apr 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.75M 496,771 shares
$13.58
$36.21
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $0 0 shares
Last Trade
Aug 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.09M 83,695 shares
$13.00
$8.75
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $732k 83,695 shares
Last Trade
Aug 23, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$906k 69,500 shares
$13.03
$8.75
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $1.34M 153,195 shares
Last Trade
Aug 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.07M 391,482 shares
$12.94
$8.75
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $4.88M 557,977 shares
Last Trade
Aug 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.53M 407,700 shares
$13.56
$8.75
ARS Pharmaceuticals
ARS Pharmaceuticals SPRY
Director
Holding Value $350k 40,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 40,000 shares
$7.73
$8.75
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $174k 15,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 15,000 shares
$2.12
$11.60
Edgewise Therapeutics
Edgewise Therapeutics EWTX
10% owner
Holding Value $746k 20,594 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$353k 20,594 shares
$17.13
$36.21
Alpine Immune Sciences
Alpine Immune Sciences ALPN
Director
Holding Value $0 0 shares
Last Trade
May 20, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.42M 68,100 shares
$64.97
$64.97
Alpine Immune Sciences
Alpine Immune Sciences ALPN
Director
Holding Value $0 0 shares
Last Trade
May 18, 2024 Sale (Tender)Reported as Tender on SEC Form 4.
$17.2M 264,315 shares
$65.00
$64.97
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
10% owner
Holding Value $16.8M 1,444,085 shares
Last Trade
May 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.67M 1,397,684 shares
$1.91
$11.60
Edgewise Therapeutics
Edgewise Therapeutics EWTX
10% owner
Holding Value $523M 14,436,497 shares
Last Trade
Jan 23, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.03M 454,545 shares
$15.46
$36.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up